Humana Inc. (HUM) is a leading health and well-being company based in Louisville, Kentucky. Founded in 1961 as a nursing home company, it has grown and evolved over time to become one of the largest and most dynamic companies in the American health insurance sector. Today, it provides health insurance and wellness solutions to millions of people throughout the United States.
Humana offers a wide range of insurance products and complementary services. These include medical insurance, specialty products like dental and vision coverage, and Medicare and Medicaid products. The company's primary focus is on health and wellness, as reflected in their company mission: to help people achieve lifelong well-being. To that end, Humana has developed a range of offerings aimed at preventing illness and promoting health, from fitness programs to home health services.
Humana's innovative approach to health care has set it apart in the industry. The company is a leader in value-based care, a health care delivery model in which doctors and hospitals are paid based on patient health outcomes rather than services rendered. Through this model, Humana aims to improve the quality of care for its members while reducing health care costs.
One of the defining aspects of Humana's corporate culture is its commitment to social responsibility. The company involves itself in various charitable endeavors and community outreach programs. It is part of the Bold Goal initiative, which aims to improve community health by 20% by 2020, and it also has a program called Humana At Home that provides home-based care for chronically ill or disabled patients.
Humana is not only a chief employer in Louisville but also has a significant presence in many other communities across the country. Over the years, the company has received multiple accolades, including being named among America’s most JUST companies according to JUST Capital and Forbes magazine.
Financially, Humana is a significant player in the healthcare sector, with revenues in the tens of billions of dollars annually. It is publicly traded on the New York Stock Exchange under the symbol HUM and is part of the Fortune 500 list of the largest corporations in the U.S.
In conclusion, Humana Inc. is more than just a health insurance company. It is a pioneer in transforming the health sector with a focus on proactive wellness, a leader in adopting value-based healthcare delivery models, and a committed supporter of the communities it serves.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
UnitedHealth (UNH) stock is up 14% in 2026, reaching $376.59 after appointing a new chief administrative officer and elevating its chief commercial officer. The company's Medicaid and Optum Health segments are projected to improve significantly in 2027, with Medicaid margins expected to recover and Optum Health's margins set to expand. Despite potential risks from Medicare Advantage audits and Star ratings, analysts anticipate strong third-quarter adjusted EPS, suggesting that holding or adding to positions before the October 13 earnings report may be favorable.
Humana Inc. shares surged by 6% after Barclays upgraded the health insurer to "overweight" from "equal-weight," anticipating a rebound in Medicare Star ratings. Analyst Andrew Mok cited increased confidence in Humana's ability to achieve "bonus status" for several contracts, particularly the critical H5216 contract which significantly impacts the company's long-term EPS target. Barclays raised Humana's price target to $515 from $407, expecting the star ratings release around October 8.
Humana Inc. shares surged 6% following Barclays' upgrade of the health insurer to "overweight" from "equal-weight." The upgrade is based on Barclays' increased confidence in Humana's potential for improved Medicare Star ratings, particularly the critical H5216 contract. Analyst Andrew Mok raised the price target to $515 from $407, citing a stronger position for Humana in the upcoming ratings cycle.
Humana's stock surged 7% after Barclays upgraded the company to Overweight and raised its price target to $515, extending an already strong year-to-date performance. This rally is company-specific, as other managed care stocks like UnitedHealth saw only modest gains, suggesting the move is driven by analyst sentiment rather than broad sector trends. Investors are now watching for other research firms to follow Barclays' lead, as the sustained gain hinges on wider acceptance of this bullish view before Humana's upcoming quarterly earnings.
Humana Inc. saw a 7.9% surge in its stock price after Barclays upgraded the health insurer to Overweight and significantly raised its price target from $407 to $515. This upgrade, coupled with potential index inclusion, suggests meaningful upside for Humana. The rally reflects strong investor interest, though future performance will depend on operational metrics such as Medicare Advantage enrollment and medical cost management.
UnitedHealth (UNH) is facing significant margin pressure in its commercial segment due to issues like arbitration abuse under the No Surprises Act and increased provider coding intensity, which a Blue Cross Blue Shield Association study linked to AI tools used by providers, costing insurers $942 million industry-wide. Management has pushed back commercial margin recovery targets to beyond 2027. UnitedHealth is responding by leveraging its Optum Insight segment, which provides AI-driven coding accuracy and prior authorization tools, to counteract these billing challenges, with its operating margin recently swinging from a loss to a record 25.4%.
State Street Corp increased its stake in Humana Inc. by 0.1% in the second quarter, acquiring an additional 4,080 shares and bringing its total holdings to 5.46 million shares, representing 4.54% of the company. Institutional investors and hedge funds now collectively own 92.38% of Humana. The company reported strong Q2 earnings with EPS of $7.61 and revenue of $40.89 billion, exceeding analyst expectations, and declared a quarterly dividend of $0.885 per share.